Surafel Mulugeta

Surafel Mulugeta

Henry Ford Hospital - Detroit / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4689449
person_outline Surafel Mulugeta's MOST POPULAR ARTICLES
1-) The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo W Gao, JY Kim, JR Anderson, T Akopian, S Hong, YY Jin, O Kandror, ... Antimicrobial agents and chemotherapy 59 (2), 880-889, 2015 1362015
2-) Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB GC Moraski, N Seeger, PA Miller, AG Oliver, HI Boshoff, S Cho, ... ACS Infectious Diseases 2 (6), 393-398, 2016 622016
3-) Bioautography with TLC-MS/NMR for rapid discovery of anti-tuberculosis lead compounds from natural sourcesEM Grzelak, C Hwang, G Cai, JW Nam, MP Choules, W Gao, DC Lankin, ...ACS infectious diseases 2 (4), 294-301, 2016532016
4-) Putting tuberculosis (TB) to rest: transformation of the sleep aid, Ambien, and “anagrams” generated potent antituberculosis agentsGC Moraski, PA Miller, MA Bailey, J Ollinger, T Parish, HI Boshoff, S Cho, ...ACS Infectious Diseases 1 (2), 85-90, 2015562015
5-) Identification and absolute configuration of dihydroxy-arachidonic acids formed by oxygenation of 5S-HETE by native and aspirin-acetylated COX-2S Mulugeta, T Suzuki, NT Hernandez, M Griesser, WE Boeglin, ...Journal of lipid research 51 (3), 575-585, 2010372010